Mounjaro’s New Cardiovascular Approval: What It Means for Diabetes and Heart Disease Treatment
by Eli Lilly’s Mounjaro (tirzepatide) has moved beyond its established role in blood-glucose management. On August 28, 2026, the U.S. Food and Drug Administration (FDA) expanded …